Colombia to Force Novartis to Lower Prices of Cancer Drug
Source: Associated Press
Colombia's government is unilaterally forcing pharmaceutical giant Novartis to lower prices of a popular leukemia drug.
Health Minister Alejandro Gaviria told reporters Thursday that two weeks of negotiations with Novartis had ended without an agreement on lowering prices.
As a result he's drafting a resolution that in the coming days will declare the drug Gleevec in the public's interest. Gaviria said the resolution will most likely lower prices of the medicine but not throw open production to generic rivals.
Gleevec has been Novartis' top-selling drug since 2012. The drugmaker's increasingly public feud with Colombia over its patent has drawn attention because of fear in the pharmaceutical industry that U.S. ally Colombia's decision will set a precedent for middle-income countries grappling to contain rising prices for complex drugs.
Read more: http://abcnews.go.com/International/wireStory/colombia-force-novartis-lower-prices-cancer-drug-39736405
By THE ASSOCIATED PRESS BOGOTA, Colombia Jun 9, 2016, 4:31 PM ET
Short article. No more at link.
DemMomma4Sanders
(274 posts)Go Columbia Go!
Vinca
(50,271 posts)Big pharma doesn't lose when it comes to profits.
chapdrum
(930 posts)permit such a grotesque violation of the free market.
Blues Heron
(5,932 posts)gleevec costs $200 to produce for a years worth for 1 person. It's not all that complex.